Human Growth Hormone Market Size, Key Players, Industry Overview, Latest Insights and Forecast 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The study provides a detailed analysis of the industry, including the global human growth hormone market size share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the human growth hormone market?

The global human growth hormone market size reached US$ 5.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

What is Human Growth Hormone?

Human growth hormone (HGH) is a critical peptide hormone produced by the pituitary gland, responsible for growth, cell reproduction, and cell regeneration in humans, thus crucial for maintaining healthy human tissue. It aids in maintaining the health of all human tissue, including that of the brain and other vital organs. When secreted, HGH remains active in the bloodstream for several minutes, allowing the liver to convert it into growth factors. The most significant of these is Insulin-like Growth Factor-1 (IGF-1), which boasts numerous anabolic properties. HGH levels naturally decrease with age, but studies have shown that certain amino acids can stimulate the release of HGH. Deficiency or excess of HGH in the body can lead to significant health problems.

Request for a sample copy of this report:  https://www.imarcgroup.com/human-growth-hormone-market/requestsample

Human Growth Hormone Market Trends:

The rising incidence of growth hormone deficiency in both children and adults represents one of the key factors driving the growth of the market across the globe. This condition is leading to abnormal growth, reduced bone mass, and a host of other health complications, which necessitate HGH therapy. The advent of recombinant DNA technology has revolutionized HGH production, leading to a consistent, safe, and sufficient supply of the hormone for therapeutic use. Additionally, advances in drug delivery methods, like the development of more comfortable and less intrusive injection devices, are improving patient compliance, which is further fueling the market's growth. The increasing investments in research and development (R&D) activities for HGH by major biopharmaceutical companies are leading to better understanding and potential new therapeutic uses of the hormone. Other factors, such as the increasing applications in sports and anti-aging therapies, the expansion of insurance coverage and governmental support, and the rising awareness about growth hormone deficiency and the importance of early diagnosis and treatment, are creating a positive outlook for the market across the globe.

Human Growth Hormone Market 2023-2028 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the human growth hormone market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• Eli Lilly and Company
• EMD Serono Inc.
• F. Hoffmann-La Roche AG
• Ferring B.V.
• Genentech Inc.
• Ipsen
• Merck KGaA
• Novartis AG
• Novo Nordisk
• Pfizer Inc.
• Sandoz, etc.

Key Market Segmentation:

The report has segmented the global human growth hormone market on the basis of application, distribution channel, route of administration and region.

Breakup by Application:

• Growth Hormone (GH) Deficiency
  • Adult GH Deficiency
  • Pediatric GH Deficiency
• Turner Syndrome
• Idiopathic Short Stature (ISS)
• Prader-Willi Syndrome (PWS)
• Small for Gestational Age
• Others

Breakup by Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Breakup by Route of Administration:

• Intravenous
• Intramuscular
• Subcutaneous
• Oral

Breakup by Region:

• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, Others)
• Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, Others)

Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=2052&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. 

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/